ArticleBMC ophthalmology2025
One-year evaluation of rotational stability and visual outcomes following horizontal, vertical, and oblique implantation of ICL V4c.
Article in BMC ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Evaluating Rotational Stability of the Visian V4b TICL in Patients with High Myopic Astigmatism.Ophthalmology and therapy · 2026Article
- Comparative analysis of 70 SMILE and 70 toric ICL eyes for myopic oblique astigmatism: a matched cohort study from an initial pool of 11,929 eyes.International ophthalmology · 2026Article
- Visual related quality of life after ICL V4c implantation in high myopia patients: a mini review.Frontiers in medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundTo evaluate and compare the rotational stability and visual outcomes of Implantable Collamer Lens (ICL) V4c implantation in horizontal, vertical, and oblique orientations and to identify risk factors contributing to postoperative lens rotation.
methodsIn this retrospective study, 502 eyes of 265 patients who underwent ICL V4c implantation for myopia correction were analyzed. Patients were categorized into three groups based on implantation orientation: horizontal, vertical, or oblique. Preoperative parameters included uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), intraocular pressure (IOP), manifest refraction spherical equivalent (MRSE), axial length (AL), anterior chamber depth (ACD), white-to-white (WTW) distance, and sulcus-to-sulcus (STS) measurements. Postoperative evaluations were conducted at 1 year and included UDVA, CDVA, MRSE, IOP, vault measurements, and rotational angles of the ICL. Logistic regression analysis was performed to determine risk factors associated with significant ICL rotation (> 5°).
resultsAll three groups achieved excellent visual outcomes, with 100% of cases attaining postoperative UDVA equal to or better than preoperative CDVA. No statistically significant differences were observed among the groups in terms of postoperative MRSE, IOP, or vault measurements. Although the mean rotational angles were comparable across the groups, the oblique implantation group demonstrated a higher incidence of rotations exceeding 5° compared to the horizontal and vertical groups. Furthermore, larger WTW distances were identified as a significant risk factor for increased rotational instability in the oblique group.
conclusionsICL V4c implantation is a highly effective procedure for myopia correction, providing excellent visual outcomes regardless of implantation orientation. However, oblique implantation, particularly in eyes with larger WTW distances, is associated with a higher risk of postoperative rotational instability. Careful consideration of WTW measurements may help minimize rotational risks in such cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.